As the worldwide scramble to find a safe and effective coronavirus vaccine continues, one Oklahoma company is hoping to take the lead. The Lynn Health Science Institute in Oklahoma City has been awarded the Moderna Phase III COVID-19 Vaccine Study slated to start July 28, 2020. Dr. Carl Griffin, the primary investigator says, "Knowing that it may be a game-changer in this world I’m very excited. " But in order for them to be successful, they need willing participants to try out the new drug.
[Source: okcfox.com] [ Comments ] [See why this is trending]